Skip to main content
. Author manuscript; available in PMC: 2020 Mar 13.
Published in final edited form as: Biometrics. 2019 Nov 10;76(1):61–74. doi: 10.1111/biom.13141

Table 3.

Proportion of variance explained (Equation (7)) for each component, estimated by BIDIFAC using the breast cancer data. The parentheses denote the rank of the estimated components.

Global Global+Row Global+Col Global+Row+Col Signal
Tumor mRNA 0.14 (34) 0.32 (68) 0.45 (93) 0.58 (127) 0.67 (173)
NAT mRNA 0.23 (34) 0.50 (68) 0.44 (4l) 0.66 (75) 0.78 (83)
Tumor miRNA 0.09 (34) 0.46 (67) 0.30 (93) 0.63 (126) 0.76 (175)
NAT miRNA 0.13 (34) 0.66 (67) 0.24 (4l) 0.75 (74) 0.76 (79)